Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HPV16 E7‐induced upregulation of KDM2A promotes cervical cancer progression by regulating miR‐132–radixin pathway

21 Aug 2018

Abstract excerpt

BACKGROUND: Human papillomavirus (HPV) infection and viral proteins expression cause a number of epigenetic alterations leading to cervical carcinogenesis. The recent discovery of a large amount of histone methylation modifiers reveals important roles of these enzymes in regulating tumor progression. METHODS: The changes in expression of 48 histone methylation modifiers were assessed following knockdown of HPV16...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cervical Cancer and HPV Research
Share to Endometrial and Cervical Cancer Treatments
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30132864
DOI: 10.1002/jcp.27080

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HPV16 E7‐induced upregulation of KDM2A promotes cervical cancer progression by regulating miR‐132–radixin pathwayPMID 30132864Read ↗

Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424–5p/suppressor of zeste 12 pathwaySemantic proximity Read ↗

Identification and validation of Nei-like DNA glycosylase 2 as a novel prognostic biomarker in cervical cancerSemantic proximity Read ↗

Epigenetics of cervical cancer. An overview and therapeutic perspectivesSemantic proximity Read ↗

The Identification and Validation of EphA7 Hypermethylation, a Novel Biomarker, in Cervical CancerSemantic proximity Read ↗

The pan-cancer analysis identified DIAPH3 as a diagnostic biomarker of clinical cancerSemantic proximity Read ↗

Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogrammingSemantic proximity Read ↗

DNA promoter methylation-dependent transcription of the double C2-like domain β (DOC2B) gene regulates tumor growth in human cervical cancer.Semantic proximity Read ↗

ESM1 mediated DNMT3A suppresses cervical cancer metastasis by epigenetic regulation of ID3 ExpressionSemantic proximity Read ↗

HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cellsSemantic proximity Read ↗

Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expressionSemantic proximity Read ↗

Suppression of miR-22, a tumor suppressor in cervical cancer, by human papillomavirus 16 E6 via a p53/miR-22/HDAC6 pathwaySemantic proximity Read ↗

DNA demethylation agent 5azadC downregulates HPV16 E6 expression in cervical cancer cell lines independently of TBX2 expressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.